Novo Nordisk rises after Wegovy gets FDA nod for liver disease

The approval comes as Novo's GLP-1 sales have decelerated.


http://dlvr.it/TMY31q

Popular Content

Scientists Discover Powerful Anti-Cancer Benefits of Popular Weight Loss Drugs

Red Hat launches unified platform for deploying and managing AI models, agents, and apps